PSTV Plus Therapeutics Inc

Price (delayed)

$5.79

Market cap

$39.85M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.55

Enterprise value

$37.56M

?
Relative Growth: Rel. Growth: 59
Relative Strength: Rel. Strength: 5
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 35

Plus Therapeutics is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company's drug development is a unique nanotechnology platform ...

Highlights
The equity has surged by 199% since the previous quarter and by 151% year-on-year
The quick ratio has soared by 123% YoY and by 90% from the previous quarter

Key stats

What are the main financial stats of PSTV

PSTV stock price

How has the Plus Therapeutics stock price performed over time
Intraday
6.83%
1 week
-9.95%
1 month
-8.1%
1 year
-34.35%
YTD
-54.8%
QTD
42.26%

Financial performance

How have Plus Therapeutics's revenue and profit performed over time
Revenue
$5.18M
Gross profit
$5.18M
Operating income
-$18.88M
Net income
-$11.93M
Gross margin
100%
Net margin
-230.2%
PSTV's net margin has surged by 56% year-on-year and by 46% since the previous quarter
Plus Therapeutics's net income has surged by 56% YoY and by 47% QoQ
PSTV's operating margin is down by 27% year-on-year and by 24% since the previous quarter
The operating income is down by 26% YoY and by 23% from the previous quarter

Price vs fundamentals

How does PSTV's price correlate with its fundamentals

Growth

What is Plus Therapeutics's growth rate over time

Valuation

What is Plus Therapeutics stock price valuation
P/E
N/A
P/B
3.32
P/S
7.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.25
The EPS has surged by 98% year-on-year and by 78% since the previous quarter
The equity has surged by 199% since the previous quarter and by 151% year-on-year
PSTV's P/B is 67% below its last 4 quarters average of 9.3
The P/S is 7% below the last 4 quarters average of 7.5

Efficiency

How efficient is Plus Therapeutics business performance
The ROA has soared by 75% YoY and by 53% from the previous quarter
The return on sales is up by 38% year-on-year and by 35% since the previous quarter

Dividends

What is PSTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PSTV.

Financial health

How did Plus Therapeutics financials performed over time
Plus Therapeutics's total assets is 150% higher than its total liabilities
The quick ratio has soared by 123% YoY and by 90% from the previous quarter
Plus Therapeutics's current ratio has soared by 120% YoY and by 85% from the previous quarter
PSTV's debt is 94% smaller than its equity
The equity has surged by 199% since the previous quarter and by 151% year-on-year
The debt to equity has dropped by 71% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.